Product Information

OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.2308 per EA under NDC 31722019401. Its NADAC has been published 477 times since Aug 16, 2017.

FDA first approved this application on Mar 22, 2017. Its Orange Book therapeutic-equivalence code is AA.

The High Outlier badge above means this manufacturer's average price in the Oxycodone and Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET

Oxycodone and Acetaminophen
$0.2308per EA
High Outlier
DEA Schedule CII

Strength

325; 10 mg/1; mg/1

NDC

31722019401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207419

FDA Approved

3/22/2017

TE Code

AA

On Market Since

4/11/2017

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET has been published 477 times since Aug 16, 2017, and over the history we have for it it has declined 46.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2308 per EA
All-time high$0.4616 (Sep 13, 2017)
All-time low$0.1580 (Sep 22, 2021)
52-week high$0.2472
52-week low$0.2292
Median price$0.2307
Average price$0.2417
Largest weekly change-22.1% (Nov 20, 2024)
Weeks tracked477
Tracking sinceAug 16, 2017

Price History

1W

0.0%

1M

-2.2%

3M

+0.1%

6M

-3.1%

1Y

-6.6%

3Y

+9.1%

5Y

+46.1%

All

-46.0%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.2308 per EA (NDC 31722019401), effective Sep 30, 2026.

How has the price of OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET has declined 46.0%. It has been tracked across 477 weekly CMS publications since Aug 16, 2017.

What are the highest and lowest recorded NADAC prices for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?

Since Aug 16, 2017, the NADAC for OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET has ranged from a low of $0.1580 (Sep 22, 2021) to a high of $0.4616 (Sep 13, 2017), with a median of $0.2307 per EA.

Are there cheaper alternatives to OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET, is $0.1796 per EA — about 22% below OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET.

Who manufactures OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET?

OXYCODONE-ACETAMINOPHEN 10-325 MG TABLET (NDC 31722019401) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.